Longitudinal study of [D₁₀]phenanthrene metabolism by the diol epoxide pathway in smokers

References

• Carmella SG, Yoder A, Hecht SS. (2006). Combined analysis of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' plasma. Cancer Epidemiol Biomarkers Prev 15:1490–4
   PubMed Web of Science ®Google Scholar
• Chu I, Ng KM, Benoit FM, Moir D. (1992). Comparative metabolism of phenanthrene in the rat and guinea pig. J Environ Sci Health Part B 27:729–49
   PubMed Web of Science ®Google Scholar
• Church TR, Anderson KE, Caporaso NE, et al. (2009). A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 18:260–6
   PubMed Web of Science ®Google Scholar
• Church TR, Anderson KE, Le C, et al. (2010). Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers. Biomarkers 15:345–52
   PubMed Web of Science ®Google Scholar
• Conney AH. (1982). Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes memorial lecture. Cancer Res 42:4875–917
   PubMed Web of Science ®Google Scholar
• Denissenko MF, Pao A, Tang M, Pfeifer GP. (1996). Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in P53. Science 274:430–2
   PubMed Web of Science ®Google Scholar
• Geacintov NE, Cosman M, Hingerty BE, Amin S, et al. (1997). NMR solution structures of stereoisometric covalent polycyclic aromatic carcinogen-DNA adduct: principles, patterns, and diversity. Chem Res Toxicol 10:111–46
   PubMed Web of Science ®Google Scholar
• Hecht SS. (1999). Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194–210
   PubMed Web of Science ®Google Scholar
• Hecht SS. (2003). Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat Rev Cancer 3:733–44
   PubMed Web of Science ®Google Scholar
• Hecht SS. (2011). Tobacco smoke carcinogens and lung cancer. In: Penning TM, ed. Chemical carcinogenesis. New York: Springer, 53–74
   Google Scholar
• Hecht SS. (2012). Research opportunities related to establishing standards for tobacco products under the family smoking prevention and tobacco control act. Nicotine Tob Res 14:18–28
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Villalta PW, Hochalter JB. (2010a). Analysis of phenanthrene and benzo[a]pyrene tetraol enantiomers in human urine: relevance to the bay region diol epoxide hypothesis of benzo[a]pyrene carcinogenesis and to biomarker studies. Chem Res Toxicol 23:900–8
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Yoder A, et al. (2006). Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol Biomarkers Prev 15:1805–11
   PubMedGoogle Scholar
• Hecht SS, Chen M, Yagi H, et al. (2003). r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation, Cancer Epidemiol Biomarkers Prev 12:1501–8
   PubMed Web of Science ®Google Scholar
• Hecht SS, Chen M, Yoder A, et al. (2005). Longitudinal study of urinary phenanthrene metabolite ratios: effect of smoking on the diol epoxide pathway, Cancer Epidemiol Biomarkers Prev 14:2969–74
   PubMed Web of Science ®Google Scholar
• Hecht SS, Villalta PW, Hochalter JB. (2008). Analysis of phenanthrene diol epoxide mercapturic acid detoxification products in human urine: relevance to molecular epidemiology studies of glutathione-S-transferase polymorphisms. Carcinogenesis 29:937–43
   PubMed Web of Science ®Google Scholar
• Hecht SS, Yuan J-M, Hatsukami DK. (2010b). Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol 23:1001–8
   PubMed Web of Science ®Google Scholar
• Hochalter JB, Zhong Y, Han S, et al. (2011). Quantitation of a minor enantiomer of phenanthrene tetraol in human urine: correlations with levels of overall phenanthrene tetraol, benzo[a]pyrene tetraol, and 1-hydroxypyrene. Chem Res Toxicol 24:262–8
   Google Scholar
• International Agency for Research on Cancer (2004). Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 83. Lyon, France: IARC
   Google Scholar
• International Agency for Research on Cancer (2010). Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 92. Lyon, France: IARC
   Google Scholar
• Kensler TW, Ng D, Carmella SG, et al. (2012). Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis 33:101–7
   PubMed Web of Science ®Google Scholar
• Luch A, Baird WM. (2005). Metabolic activation and detoxification of polycyclic aromatic hydrocarbons. In: Luch A, ed. The carcinogenic effects of polycyclic aromatic hydrocarbons. London: Imperial College Press, 19–96
   Google Scholar
• Nordquist M, Thakker DR, Vyas KP, et al. (1981). Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes. Mol Pharmacol 19:168–78
   PubMed Web of Science ®Google Scholar
• Pfeifer GP, Besaratinia A. (2009). Mutational spectra of human cancer. Hum Genet 125:493–506
   PubMed Web of Science ®Google Scholar
• Rojas M, Alexandrov K, Cascorbi I, et al. (1998). High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1*0/*0 genotypes. Pharmacogenetics 8:109–18
   PubMedGoogle Scholar
• Shafey O, Eriksen MP, Ross H, Mackay J. (2009). The tobacco atlas. 3rd ed. Atlanta (GA): American Cancer Society and World Lung Foundation
   Google Scholar
• Shou M, Korzekwa KR, Krausz KW, et al. (1994). Regio- and stereo-selective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450. Cancer Lett 83:305–13
   PubMed Web of Science ®Google Scholar
• St Helen G, Goniewicz ML, Dempsey D, et al. (2012). Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. Chem Res Toxicol 25:952–64
   PubMed Web of Science ®Google Scholar
• Thakker DR, Yagi H, Levin W, et al. (1985). Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In: Anders MW, ed. Bioactivation of foreign compounds. New York: Academic Press, Inc., 177–242
   Google Scholar
• United States Department of Health and Human Services (2010). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Chap. 5. Washington (DC): U.S. Department of Health and Human Services
   Google Scholar
• Upadhyaya P, Rao P, Hochalter JB, et al. (2006). Quantitation of N-acetyl-S-(9,10-dihydro-9-hydroxy-10-phenanthryl)-L-cysteine in human urine: comparison with glutathione-S-transferase genotypes in smokers. Chem Res Toxicol 19:1234–40
   PubMed Web of Science ®Google Scholar
• Wang J, Zhong Y, Carmella SG, et al. (2012). Phenanthrene metabolism in smokers: use of a two-step diagnostic plot approach to identify subjects with extensive metabolic activation. J Pharmacol Exp Ther 342:750–60
   Google Scholar
• Yuan J-M, Gao Y-T, Murphy SE, et al. (2011). Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res 71:6749–57
   PubMed Web of Science ®Google Scholar
• Zhong Y, Carmella SG, Hochalter JB, et al. (2010). Analysis of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene in human urine: a biomarker for directly assessing carcinogenic polycyclic aromatic hydrocarbon exposure plus metabolic activation. Chem Res Toxicol 24:73–80
   Google Scholar
• Zhong Y, Carmella SG, Upadhyaya P, et al. (2011a). Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides. Chem Res Toxicol 24:246–52
   PubMed Web of Science ®Google Scholar
• Zhong Y, Wang J, Carmella SG, et al. (2011b). Metabolism of [D10]phenanthrene to tetraols in smokers for potential lung cancer susceptibility assessment: Comparison of oral and inhalation routes of administration. J Pharmacol Exp Ther 338:353–61
   Google Scholar